Nab-paclitaxel-based compared to docetaxel-based induction chemotherapy regimens for locally advanced squamous cell carcinoma of the head and neck

We previously reported that nab-paclitaxel-based induction chemotherapy (IC) and concurrent chemoradiotherapy resulted in low relapse rates (13%) and excellent survival in head and neck squamous cell carcinoma (HNSCC). We compare the disease-specific survival (DSS) and overall survival (OS) between...

Descripción completa

Detalles Bibliográficos
Autores principales: Schell, Amy, Ley, Jessica, Wu, Ningying, Trinkaus, Kathryn, Wildes, Tanya Marya, Michel, Loren, Thorstad, Wade, Gay, Hiram, Lewis, James, Rich, Jason, Diaz, Jason, Paniello, Randal C, Nussenbaum, Brian, Adkins, Douglas R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2015
Materias:
Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4402061/
https://www.ncbi.nlm.nih.gov/pubmed/25619559
http://dx.doi.org/10.1002/cam4.382

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4402061/
https://www.ncbi.nlm.nih.gov/pubmed/25619559
http://dx.doi.org/10.1002/cam4.382

Ejemplares similares